173 related articles for article (PubMed ID: 33471519)
21. In vitro and in vivo anti-Helicobacter pylori activity of Casearia sylvestris leaf derivatives.
Spósito L; Oda FB; Vieira JH; Carvalho FA; Dos Santos Ramos MA; de Castro RC; Crevelin EJ; Crotti AEM; Santos AG; da Silva PB; Chorilli M; Bauab TM
J Ethnopharmacol; 2019 Apr; 233():1-12. PubMed ID: 30594606
[TBL] [Abstract][Full Text] [Related]
22. Is the only good Helicobacter a dead Helicobacter?
Misiewicz JJ
Helicobacter; 1997 Jul; 2 Suppl 1():S89-91. PubMed ID: 9432362
[TBL] [Abstract][Full Text] [Related]
23. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from
Tabassum H; Ahmad IZ
Med Chem; 2021; 17(2):146-157. PubMed ID: 32116195
[TBL] [Abstract][Full Text] [Related]
24. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury.
Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ
J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309
[TBL] [Abstract][Full Text] [Related]
25. Potential of fumarate reductase as a novel therapeutic target in Helicobacter pylori infection.
Ge Z
Expert Opin Ther Targets; 2002 Apr; 6(2):135-46. PubMed ID: 12223076
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial activities of peptide Cbf-K
Jiang M; Ma L; Huang Y; Wu H; Dou J; Zhou C
Microb Pathog; 2020 Jan; 138():103847. PubMed ID: 31704464
[TBL] [Abstract][Full Text] [Related]
27. Selective Targeting of Human and Animal Pathogens of the
Salillas S; Galano-Frutos JJ; Mahía A; Maity R; Conde-Giménez M; Anoz-Carbonell E; Berlamont H; Velazquez-Campoy A; Touati E; Mamat U; Schaible UE; Gálvez JA; Díaz-de-Villegas MD; Haesebrouck F; Aínsa JA; Sancho J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576300
[TBL] [Abstract][Full Text] [Related]
28. Impact of
Iino C; Shimoyama T
World J Gastroenterol; 2021 Oct; 27(37):6224-6230. PubMed ID: 34712028
[TBL] [Abstract][Full Text] [Related]
29. Studies on anti-Helicobacter pylori agents. Part 1: Benzyloxyisoquinoline derivatives.
Yoshida Y; Barrett D; Azami H; Morinaga C; Matsumoto S; Matsumoto Y; Takasugi H
Bioorg Med Chem; 1999 Nov; 7(11):2647-66. PubMed ID: 10632076
[TBL] [Abstract][Full Text] [Related]
30. Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection.
Juvale K; Purushothaman G; Singh V; Shaik A; Ravi S; Thiruvenkatam V; Kirubakaran S
Sci Rep; 2019 Jan; 9(1):190. PubMed ID: 30655593
[TBL] [Abstract][Full Text] [Related]
31. Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection.
Menchicchi B; Hensel A; Goycoolea FM
Curr Pharm Des; 2015; 21(33):4888-906. PubMed ID: 26290206
[TBL] [Abstract][Full Text] [Related]
32. Second-line rescue treatment of
Lin TF; Hsu PI
World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
[TBL] [Abstract][Full Text] [Related]
33.
Chung JW; Kim SY; Park HJ; Chung CS; Lee HW; Lee SM; Kim I; Pak JH; Lee GH; Jeong JY
Gut Liver; 2017 Sep; 11(5):648-654. PubMed ID: 28750485
[TBL] [Abstract][Full Text] [Related]
34. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
35. Treatment of
Lee S; Sneed GT; Brown JN
Infect Dis (Lond); 2020 Jun; 52(6):381-390. PubMed ID: 31900002
[No Abstract] [Full Text] [Related]
36. Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates.
Kouitcheu Mabeku LB; Eyoum Bille B; Tepap Zemnou C; Tali Nguefack LD; Leundji H
BMC Infect Dis; 2019 Oct; 19(1):880. PubMed ID: 31640588
[TBL] [Abstract][Full Text] [Related]
37. A review on the structures and biological activities of anti-Helicobacter pylori agents.
Ghobadi E; Ghanbarimasir Z; Emami S
Eur J Med Chem; 2021 Nov; 223():113669. PubMed ID: 34218084
[TBL] [Abstract][Full Text] [Related]
38. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.
Ling TK; Cheng AF; Sung JJ; Yiu PY; Chung SS
Helicobacter; 1996 Mar; 1(1):57-61. PubMed ID: 9398914
[TBL] [Abstract][Full Text] [Related]
39. Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection.
Cremades N; Velázquez-Campoy A; Martínez-Júlvez M; Neira JL; Pérez-Dorado I; Hermoso J; Jiménez P; Lanas A; Hoffman PS; Sancho J
ACS Chem Biol; 2009 Nov; 4(11):928-38. PubMed ID: 19725577
[TBL] [Abstract][Full Text] [Related]
40. Gut Microbiota: The Missing Link Between
Martin-Nuñez GM; Cornejo-Pareja I; Clemente-Postigo M; Tinahones FJ
Front Endocrinol (Lausanne); 2021; 12():639856. PubMed ID: 34220702
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
